How to Trip Rapid Review
Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)
Step 2: press
Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.
- 699 results
- Evidence type
- Clinical Area
Use check boxes to select individual results below
SmartSearch available
Trip's SmartSearch engine has discovered connected searches & results. Click to show41. Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors
in the adult. Can J Cardiol . 2013;29(2):151-167. 42. Perk J, De Backer G, Gohlke H, et al; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies (...) Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Adults The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular
2018 U.S. Preventive Services Task Force
42. Cardiovascular Disease Risk: Screening With Electrocardiography
(from the National Health and Nutrition Examination Survey-III). Am J Cardiol . 2013;112(6):805-10. 29. Shah AJ, Vaccarino V, Janssens AC, et al. An electrocardiogram-based risk equation for incident cardiovascular disease from the National Health and Nutrition Examination Survey. JAMA Cardiol . 2016;1(7):779-86. 30. Myers J, Arena R, Franklin B, et al; American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention of the Council on Clinical Cardiology, the Council (...) Cardiovascular Disease Risk: Screening With Electrocardiography Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Adults at low risk of CVD events The USPSTF recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events. D Adults at intermediate or high risk of CVD events The USPSTF concludes
2018 U.S. Preventive Services Task Force
43. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes Full Text available with Trip Pro
and Pericardial Diseases of the European Society of Cardiology. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J . 2005 ; 26 :516–524. doi: 10.1093/eurheartj/ehi108. Corrado D (...) Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search
2015 American Heart Association
44. Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease
Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search October 2019 September 2019 August 2019 July 2019 June 2019 May (...) 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association , MD, FAHA, Chair , PhD, PT, FAHA, Co-Chair , MD, MS , RN, PhD , PhD, MSc, BSR
2017 American Heart Association
45. The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association
The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January (...) 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association , MD, MSc, FAHA, Chair , PhD, CCNS, FAHA , MD, FAHA , PhD, FAHA , MD, FAHA , MD , MD, MAS, FAHA , MD, MPH, FAHA , MD, MSc, FAHA , MD, PhD, FAHA , and PhD MDOn behalf of the American Heart Association Council on Quality of Care
2017 American Heart Association
46. Evidence for Therapeutic Patient Education Interventions to Promote Cardiovascular Patient Self-Management: A Scientific Statement for Healthcare Professionals From the American Heart Association Full Text available with Trip Pro
predicted change in kilocalories expended (P=0.03) ACS indicates acute coronary syndrome; C, control; CABG, coronary artery bypass graft; CAD, coronary artery disease; CD, compact disc; CR, cardiac rehabilitation; CVD, cardiovascular disease; F/U, follow-up; GP, general practitioner; I, intervention; MI, myocardial infarction; PCI, percutaneous coronary intervention; PT, physical therapist; RCT, randomized controlled trial; RN, registered nurse; SF36, 36-Item Short-Form Health Survey; TPE, therapeutic (...) Evidence for Therapeutic Patient Education Interventions to Promote Cardiovascular Patient Self-Management: A Scientific Statement for Healthcare Professionals From the American Heart Association 1 A lthough the overall rate of death associated with cardio- vascular disease (CVD) continues to decline in the United States, 1–3 CVD is a leading cause of mortality and disability. The burden of CVD remains high, underscoring the need to improve long-term management of CVD as a chronic illness
2017 American Heart Association
47. The Canadian Cardiovascular Society heart failure companion: bridging guidelines to your practice
The Canadian Cardiovascular Society heart failure companion: bridging guidelines to your practice Special Article The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice Jonathan G. Howlett, MD, FRCPC, a Michael Chan, MBBS, FRCPC, FACC, b Justin A. Ezekowitz, MBBCh, MSc, FRCPC, c Karen Harkness, RN, PhD, d George A. Heckman, MD, FRCPC, e Simon Kouz, MD, FRCPC, f Marie-H elène Leblanc, MD, FRCPC, g Gordon W. Moe, MD, FRCPC, h Eileen O’Meara, MD, FRCPC, i (...) Howard Abrams, MD, FRCPC, j Anique Ducharme, MD, FRCPC, i Adam Grzeslo, MD, CCFP, d Peter G. Hamilton, MBBCh, FRCPC, c Sheri L. Koshman, PharmD, ACRP, c Serge Lepage, MD, FRCPC, k Michael McDonald, MD, FRCPC, l Robert McKelvie, MD, PhD, FRCPC, d Miroslaw Rajda, MD, FRCPC, m Elizabeth Swiggum, MD, FRCPC, n Sean Virani, MD, FRCPC, o and Shelley Zieroth, MD, FRCPC; p for the Canadian Cardiovascular Society Heart Failure Guidelines Panels a University of Calgary and Libin Cardiovascular Institute
2016 CPG Infobase
48. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE)
groups. 3 The 2014 update is a harmonized subset of recommendations from the following guideline groups: Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-informed Tobacco Treatment; 4 Cana- dian Association of Cardiac Rehabilitation; 5 Canadian Cardiovascular Society; 6 Canadian Diabetes Association; 7 Canadian Hypertension Education Program; 8 Canadian Society for Exer- cise Physiology; 9 Heart and Stroke Foundation Canadian Stroke Best Practice Recommenda- tions (...) • Patient resource centre: www.cchangeinme.com • Guidelines app (will be available from the App Store) Participating guideline groups • Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-informed Tobacco Treatment: www .nicotinedependenceclinic.com/English/CANADAPTT/Pages/Home.aspx • Canadian Association of Cardiac Rehabilitation: www.cacpr.ca • Canadian Cardiovascular Society (dyslipidemia guideline): www .ccsguidelineprograms.ca/index.php?option=com_content&view
2015 CPG Infobase
49. Cancer treatments & cardiovascular toxicity 2016 (Position Paper) Full Text available with Trip Pro
Cancer treatments & cardiovascular toxicity 2016 (Position Paper) We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite (...) Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation 21 September 2016 Article Contents Article Navigation 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) Jose Luis Zamorano (Chairperson) (Spain) Corresponding authors: Jose Luis
2016 European Society of Cardiology
50. Canadian cardiovascular society guidelines for the diagnosis and management of stable ischemic heart disease
: Canadian Association of Cardiac Rehabilitation, 2009. 15. Wait Time Alliance. Wait-time benchmarks for cardiovascular services and procedures in Wait Time Alliance for Timely Access to Health Care. It’s About Time: Achieving Benchmarks and Best Practices in Wait Time Management. Available at: http://www.waittimealliance.ca/ wp-content/uploads/2014/05/Cardiovasuclar_Services_and_Procedures. pdf. Accessed July 3, 2014. 16. Choosing Wisely. American College of Cardiology. Five Things Phy- sicians (...) Canadian cardiovascular society guidelines for the diagnosis and management of stable ischemic heart disease Society Guidelines Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease G.B. John Mancini, MD (Co-Chair), a Gilbert Gosselin, MD (Co-Chair), b Benjamin Chow, MD, c William Kostuk, MD, d James Stone, MD, PhD, e Kenneth J. Yvorchuk, MD, CM, f Beth L. Abramson, MD, MSc, g Raymond Cartier, MD, b Victor Huckell, MD, a Jean-Claude Tardif
2014 CPG Infobase
51. Medical Training to Achieve Competency in Lifestyle Counseling: An Essential Foundation for Prevention and Treatment of Cardiovascular Diseases and Other Chronic Medical Conditions: A Scientific Statement From the American Heart Association Full Text available with Trip Pro
; the Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; and the Council on Cardiovascular and Stroke Nursing Marie-France Hivert , Ross Arena , Daniel E. Forman , Penny M. Kris-Etherton , Patrick E. McBride , Russell R. Pate , Bonnie Spring , Jennifer Trilk , Linda V. Van Horn , and William E. Kraus and On behalf of the American Heart Association Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; the Behavior Change (...) Committee, a joint committee of the Council on Lifestyle and Cardiometabolic Health and the Council on Epidemiology and Prevention; the Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; and the Council on Cardiovascular and Stroke Nursing Originally published 6 Sep 2016 Circulation. 2016;134:e308–e327 You are viewing the most recent version of this article. Previous versions: Introduction A healthy lifestyle is fundamental for the prevention
2016 American Heart Association
52. Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association
Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 This site (...) uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association , PhD, CNP, FAHA, Chair , PhD, MS, RN, FAHA, Co-Chair , MD, MSPH, Co-Chair , MD , PhD , MD , MD, MPH, MBA, FAHA , PhD, MPH , MD , MD, FAHA , PhD, LICSW , MD , MPH , MD , PhD, MPH, JD , MD , PhD, RN, FAHA , PA, FNP, JD
2016 American Heart Association
53. Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association Full Text available with Trip Pro
Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 (...) January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association , MD, FAHA, Chair , PhD , MD , MD, FAHA , PhD , MSN, APRN, FAHA , DO, MHA, FAHA , DNS, RN , PhD , RN, MSEE, PhD , JD , RN, MPH, JD , MPH, JD
2016 American Heart Association
54. Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association Full Text available with Trip Pro
Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 (...) January 2019 Free Access article Share on Jump to Free Access article Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association , PhD, FAHA, Chair , MD, MMSc, FAHA, Co-Chair , PhD , PhD, FAHA , PhD, FAHA , PhD, FAHA , MD, MSPH, FAHA , PhD , PhD, FNP, FAHA , and DrPH MD, MBA, MScOn behalf of the Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Epidemiology
2016 American Heart Association
55. Knowledge Gaps in Cardiovascular Care of the Older Adult Population Full Text available with Trip Pro
Knowledge Gaps in Cardiovascular Care of the Older Adult Population Knowledge Gaps in Cardiovascular Care of the Older Adult Population | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use (...) of cookies. Free Access article Share on Jump to Free Access article Knowledge Gaps in Cardiovascular Care of the Older Adult Population A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society , MD, FAHA, FACC, Chair , PhD, RN, FAHA, Co-Chair , MD, FACC , MD, FAHA, FACC , MD, FACC , MD, FAHA, FACC , MD, FACC , MD, FACC , PhD, CRNP , MD, FAHA, FACC , and MD, MSc, FAHA Michael W. Rich , Deborah A. Chyun , Adam H. Skolnick , Karen P
2016 American Heart Association
56. Prevention of Cardiovascular Disease in Women
Prevention of Cardiovascular Disease in Women 2016 Prevention of Cardiovascular in women (2 nd edition) Disease 1 2016 STATEMENT OF INTENT This guideline was developed to be a guide for best clinical practice in the management of cardiovascular diseases in women, based on the best available evidence at the time of development. Specific attempts were made to use local data and publications to ensure local relevance. Adherence to this guideline does not necessarily lead to the best clinical (...) Available on the following websites: http://www.moh.gov.my http://www.acadmed.org.my This is an update to the Clinical Practice Guidelines on Prevention of Heart Disease in Women published in 2008. This CPG supersedes the previous CPG.FOREWORD BY THE DIRECTOR-GENERAL OF THE MINISTRY OF HEALTH MALAYSIA 2 2016 Datuk Dr Noor Hisham Abdullah Director-General of Health Malaysia Cardiovascular disease, till this day, remains the primary cause of mortality globally. Although it affects both genders, a greater
2016 Ministry of Health, Malaysia
57. Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention Full Text available with Trip Pro
Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access (...) article Share on Jump to Free Access article Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention A Scientific Statement From the American Heart Association , PhD, MPH, FAHA, Chair , MD, PhD, FAHA , MSN/MPH, BSN, RN , PhD , MD , PhD, MSN, RN , PhD , BSN, PhD(c), RN , MD, MHS , MD, MS , MD, FAHA , PhD, FAHA , and MD, MS, FAHA PhD, RNon behalf of the American Heart Association Publications Committee of the Council on Epidemiology and Prevention, Behavior Change
2015 American Heart Association
58. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations
was consistent with the then-current 26th Bethesda Conference guidelines), established the current legal framework for resolving athlete challenges to medical disqualification based on cardiovascular abnormalities or events. Nicholas Knapp sued Northwestern University, claiming that its refusal to allow him to play on its basketball team violated the Rehabilitation Act, a federal law prohibiting educational institutions that receive federal funds from discriminating against people with covered disabilities (...) Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March
2015 American Heart Association
59. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies Full Text available with Trip Pro
, Hoffmann A, Hoffmann E, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G ; Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology; Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working (...) Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019
2015 American Heart Association
60. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 (...) February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects A Scientific Statement From the American Heart Association and American College of Cardiology , MD
2015 American Heart Association
Guidelines
Guidelines – filter by country